Publisher DOI: | 10.1007/s00430-004-0229-y | Title: | Complement C3 is required for the progression of cutaneous lesions and neutrophil attraction in Leishmania major infection | Language: | English | Authors: | Jacobs, Thomas Andrä, Jörg Gaworski, Iris Graefe, Sebastian Mellenthin, Katja Krömer, Manfred Halter, Roman Borlak, Jürgen Clos, Joachim |
Keywords: | Transgenic mice; Cobra venom factor; Leishmania major; Complement C3; Neutrophil | Issue Date: | 17-Sep-2004 | Publisher: | Springer | Journal or Series Name: | Medical microbiology and immunology | Volume: | 194 | Issue: | 3 | Startpage: | 143 | Endpage: | 149 | Abstract: | To elucidate the role of complement-mediated uptake in Leishmania major infection in vivo, transgenic BALB/c mice that express the cobra venom factor (CVF) under control of the α1-antitrypsin promoter were infected. CVF expression in these mice leads to a continuous activation and subsequent consumption of complement C3 in the serum. In contrast to susceptible non-transgenic BALB/c mice, CVF-transgenic mice are highly resistant to L. major infection and show a significantly reduced parasite dissemination. Transient depletion of C3 in wild-type BALB/c mice delays progression of lesions for some days. Both CVF-transgenic and non-transgenic mice exhibit similar T cell responses upon infection. However, in CVF-transgenic mice, no infiltration of neutrophils, which were the prominent infiltrating cells at the site of infection in normal susceptible mice, could be detected. We conclude that C3 cleavage is required for the attraction of neutrophils that participate in parasite dissemination. |
URI: | http://hdl.handle.net/20.500.12738/2020 | ISSN: | 1432-1831 | Review status: | This version was peer reviewed (peer review) | Institute: | Forschungszentrum Borstel Universität Hamburg |
Type: | Article |
Appears in Collections: | Publications without full text |
Show full item record
Add Files to Item
Note about this record
Export
Items in REPOSIT are protected by copyright, with all rights reserved, unless otherwise indicated.